Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Escitalopram in Acute Stroke (ESTIAS)
NCT01561092Phase 4Withdrawn
- Sponsor
- Aarhus University
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Escitalopram oxalate oral solution in ischemic stroke (2 arms), sponsored by Aarhus University. Primary endpoint: New vascular events at 6 months. Status: withdrawn.
02
Drugs
Escitalopram oxalate oral solution
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT01561092.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01561092.